A

Amylyx Pharmaceuticals

Biopharmaceutical company developing neurodegenerative therapies

Regional Sales Director

Field SalesConfirmed live in the last 24 hours
Full-timeUnited States

About the Job

Requirements

  • A bachelor's degree is required; equivalent combinations of education and experience will be considered.
  • At least 10 years of progressive pharmaceutical or biotechnology commercial experience, including at least 3 years of successful field sales leadership and people management.
  • Demonstrated success in rare disease, endocrinology, metabolic disease, or another specialty market involving complex diagnosis, referral, treatment, reimbursement, and patient-support pathways.
  • A proven record of recruiting and developing talent, leading through change, setting high standards, and delivering results through others in a compliant manner.
  • Ability to translate enterprise and brand priorities into clear regional and territory plans, measurable objectives, and consistent field execution.
  • Strong business and analytical acumen, including experience using customer relationship management (CRM), market, account, and performance data for opportunity assessment, resource allocation, and decision-making.
  • Track record of effective matrix leadership with Marketing, Medical Affairs, Market Access, Patient Services, Commercial Operations, Training, and Compliance partners.
  • Excellent communication, coaching, influencing, and relationship-management skills, with the judgment and adaptability to operate in an evolving pre-launch and launch environment.
  • Valid driver's license and ability to meet the travel requirements of the role.

Responsibilities

  • Recruit, hire, onboard, lead, coach, and retain a high-performing team of field sales professionals; establish clear expectations, individualized development plans, and succession readiness.
  • Own the regional business plan by translating post-bariatric hypoglycemia (PBH) brand priorities into territory strategies, account plans, customer-engagement objectives, resource allocation, and measurable execution standards.
  • Establish a disciplined operating rhythm that includes field coaching, business reviews, performance tracking, opportunity planning, and timely course correction to ensure performance objectives are met or exceeded.
  • Use CRM data, market intelligence, account insights, referral-network dynamics, and leading indicators to identify opportunities and risks, prioritize resources, and improve regional performance.
  • Spend substantial time in the field observing customer engagement and providing timely, behavior-based coaching on clinical dialogue, pre-call planning, account strategy, reimbursement, patient-support resources, and execution excellence.
  • Set clear performance expectations, recognize strong performance, and address capability or execution gaps through direct feedback, documented development actions, and appropriate performance management.
  • Develop productive relationships with priority health systems, bariatric programs, endocrinology and metabolic care teams, key experts, and other stakeholders involved in PBH diagnosis, referral, treatment, access, and patient support.
  • Manage the regional budget and other company resources responsibly, ensuring regional investments align with strategic priorities and company policies.
  • Model Amylyx values and maintain high standards of ethics, compliance, accountability, inclusion, and respect for patients and caregivers.

Desired Qualifications

  • Experience building or scaling a field team and leading launch-readiness or product-launch execution in a rare disease or specialty market.
  • Knowledge of bariatric surgery care pathways, endocrinology, hypoglycemia, specialty pharmacy, reimbursement, and patient-support services.
  • Established understanding of the healthcare landscape, including priority health systems, integrated delivery networks, and referral networks.

About the Company

Amylyx Pharmaceuticals

Biopharmaceutical company developing neurodegenerative therapies

Amylyx Pharmaceuticals develops treatments for neurodegenerative diseases, with a focus on ALS and Alzheimer's disease. Its main asset is AMX0035, currently in clinical trials, including the CENTAUR study for ALS and the PEGASUS study for late mild cognitive impairment or early dementia due to Alzheimer’s disease. The company advances products through rigorous, randomized, double-blind, placebo-controlled trials to demonstrate safety and efficacy before pursuing commercialization. In addition to research, Amylyx engages in awareness and community campaigns to support patients, caregivers, and researchers. The company aims to bring validated therapies to market to improve patient outcomes and generate revenue by selling treatments to healthcare providers and patients.

Company size
51-200
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2013

Recently Posted Jobs

Explore more opportunities at Amylyx Pharmaceuticals

See more jobs